Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
Department of Obstetrics and Gynecology, University of California, Los Angeles, Los Angeles, California, USA.
J Womens Health (Larchmt). 2023 May;32(5):546-552. doi: 10.1089/jwh.2022.0094. Epub 2023 Apr 6.
The aim of this study is to examine complementary and alternative medicine (CAM) use among women with symptomatic uterine fibroids in the United States. In this cross-sectional analysis of baseline data from a multicenter, prospective cohort study of premenopausal women undergoing surgery for symptomatic fibroids and who enrolled in the Uterine Leiomyoma Treatment with Radiofrequency Ablation study from 2017 to 2019, we contrast women indicating use of at least one CAM modality specifically for fibroid symptoms against women using CAM for other reasons and CAM nonusers. Multivariable logistic regression models were performed to identify participant characteristics independently associated with CAM use for fibroids. Among 204 women, 55% were Black/African American and the mean age was 42 (standard deviation 6.6) years. CAM use was common (67%), with 42% (95% confidence interval [CI]: 35%-49%) reporting use of CAM specifically to treat fibroid symptoms. Most commonly, CAM treatments used for fibroids were diet (62%) and herbs (52%), while CAM treatments for other reasons were exercise (80%) and massage (43%). On average, each participant who reported CAM use utilized three different types of CAM modalities. In a multivariable model, participants were more likely to use CAM for fibroids if they had pelvic pressure (odds ratio [OR] 2.50, 95% CI: 1.07-5.87, = 0.04), a body-mass index lower than average (OR 0.76, 95% CI: 0.60-0.97, = 0.03), and a lower health-related quality of life score (OR 0.61, 95% CI: 0.46-0.81, = 0.001). In this diverse sample of women with symptomatic fibroids, CAM use was highly prevalent. Our findings highlight the need for providers to query patients about CAM use and understand the role of CAM in fibroid management. ClinicalTrials.gov Identifier: NCT02100904.
本研究旨在考察美国有症状子宫肌瘤女性中补充和替代医学(CAM)的使用情况。在这项针对 2017 年至 2019 年间接受手术治疗有症状子宫肌瘤且参加了子宫肌瘤射频消融治疗多中心前瞻性队列研究的绝经前女性的基线数据的横断面分析中,我们将明确表示至少使用一种 CAM 治疗方法专门治疗肌瘤症状的女性与因其他原因使用 CAM 和不使用 CAM 的女性进行了对比。采用多变量逻辑回归模型来确定与使用 CAM 治疗肌瘤独立相关的参与者特征。在 204 名女性中,55%为黑人/非裔美国人,平均年龄为 42 岁(标准差为 6.6 岁)。CAM 的使用率很高(67%),其中 42%(95%置信区间[CI]:35%-49%)报告说使用 CAM 专门治疗肌瘤症状。最常使用的治疗肌瘤的 CAM 治疗方法是饮食(62%)和草药(52%),而因其他原因使用的 CAM 治疗方法是运动(80%)和按摩(43%)。平均而言,每个报告使用 CAM 的参与者使用了三种不同类型的 CAM 治疗方法。在多变量模型中,如果参与者有骨盆压迫感(比值比[OR]2.50,95%CI:1.07-5.87, = 0.04)、体重指数低于平均值(OR 0.76,95%CI:0.60-0.97, = 0.03)和健康相关生活质量评分较低(OR 0.61,95%CI:0.46-0.81, = 0.001),他们更有可能使用 CAM 治疗肌瘤。在这个有症状子宫肌瘤的多样化女性样本中,CAM 的使用率很高。我们的研究结果强调了提供者需要询问患者关于 CAM 的使用情况,并了解 CAM 在肌瘤管理中的作用。临床试验.gov 标识符:NCT02100904。